Home / Clinics Supported / Joint & Musculoskeletal
Open a Joint Pain Clinic
Where Aging Joints Meet Athletic Recovery.
The chronic joint pain patient and the active patient seeking faster recovery are both searching, and in many U.S. markets no dedicated non-surgical clinic is answering them.
Book a Strategy CallNo medical background is required to own the business. An independent, state-licensed Medical Director directs all clinical care.
Two Patient Populations.
One Joint Pain Clinic.
The first patient is 55 with chronic knee pain, told the only options are a cortisone shot or eventual surgery, and searching for a non-surgical alternative such as platelet-rich plasma or shockwave therapy.
The second patient is 38, trains regularly, and wants faster recovery from a shoulder injury, paid out of pocket if it goes beyond physical therapy.
Both are searching: U.S. searches for “PRP injections” run 10,000 to 100,000 a month (Google Keyword Planner). Our wellness clinic launch consulting helps you open one clinic that serves both, without the lifetime royalties of a joint clinic franchise.
The patient who finds a non-surgical option at your clinic doesn't forget it, and that gratitude can drive the referrals these clinics grow on.
Knee, hip, shoulder pain
Avoiding surgery
Referred by primary care
Sports injuries, tendon issues
Faster recovery goal
Finds via search & community
What a Joint & Musculoskeletal Clinic Offers Patients
In many mid-sized markets, no dedicated clinic offers PRP, shockwave and recovery care under one roof.
Concentrated growth factors from the patient's own blood, used in joint and tendon injections. The category anchor service.
Extracorporeal shockwave for patients with tendon and ligament pain, used only within each device's FDA-cleared or approved uses. Equipment-based, with low consumable cost.
Dextrose-based injections into ligaments and tendons, a low-cost, office-based service your Medical Director directs.
Athletic patients ask for BPC-157 and TB-500 by name, but neither is FDA-approved or on the 503A Bulks List, and both rest on a temporary HHS enforcement discretion policy (October 2026), not a listing or an approval. ACG scopes adjuncts around sermorelin and FDA-approved agents for your Medical Director; see Peptide Therapy for the status table.
A premium add-on for sports recovery. FDA clears hyperbaric oxygen only for specific conditions, so recovery uses carry no treatment claims.
Photobiomodulation for post-procedure recovery support, marketed within the device's FDA clearance.
Joint Pain Clinic Consulting,
From Market to Opening Day
From equipment sourcing to the Medical Director to the brand that positions you against the orthopedic surgeon next door, ACG plans each step with you before your first patient walks in.
Identify whether your market suits joint-focus, sports-recovery focus, or dual positioning, before committing capital.
Entity structure, state licensing, Medical Director introduction and oversight agreement for PRP and regenerative procedures.
Shockwave equipment, PRP kits and HBOT sourcing at preferred pricing through ACG's vendor network.
Non-surgical positioning for the patient who was told surgery was the only option, and a marketing strategy to match. Marketing execution is a separate engagement.
Grand opening planning and 60 days of post-launch advisory on referrals and patient flow.
Questions About Opening
a Joint Pain Clinic
Straight answers on PRP and prolotherapy compliance, franchises, equipment and cash-pay structure. Anything else, ask on the strategy call.
View All FAQsWhat services does a joint and musculoskeletal regenerative clinic offer?
What are the state and federal regulations around PRP and regenerative protocols?
Do I need to be a physician to open a regenerative joint clinic?
Should I buy a joint clinic franchise or open my own?
What equipment investment is required to launch?
Should the clinic accept insurance or operate cash-pay only?
Where Cellular Products Fit in a Joint Clinic
Musculoskeletal is the largest application segment in the stem cell category (Coherent Market Insights, 2024), so a joint clinic is a common entry point for adding a cellular service line to an existing practice. The FDA scrutinizes it closely: orthopedic uses are where birth-tissue and umbilical-derived products tend to fail the homologous use test and need premarket approval.
Demand is not the constraint here. A defensible answer to the 361 vs 351 question is. Build that first and the rest of the clinic is straightforward.
Next Steps for Your Joint Pain Clinic
Open Your Joint Pain Clinic With the Team Behind Hundreds of Launches
Your market is searching for the non-surgical alternative. Talk with Grayson Miller about local demand, the compliance picture and what opening takes. No pitch. No obligation.
- Local demand review
- A modality plan that holds up
- An honest read on fit
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary. The 60-day target begins from clinic keys received, market and regulatory conditions permitting.
Structured to keep you on the right side of the line.
Knowing the rules is the foundation of every clinic we help launch.
Your Medical Director Directs Care
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
We Know the Regulatory Lines
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
No Hype. No Guarantees.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.